Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Summary

The purpose of this study is to evaluate the efficacy of levofloxacin to prevent bacterial infections in the postneutropenic period in patients who have undergone allogeneic stem cell transplantation (SCT).

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications